LAMEA Women Health Diagnostics Market

LAMEA Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others (Osteoporosis Testing and Prenatal Genetic Testing)), and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) Forecast Period 2019-2025
    Update Available - Forecast 2024-2030   

Published: Feb 2020 | Report Code: OMR2021203 | Category : Medical Devices | Delivery Format: /

LAMEA women health diagnostics market is growing at a CAGR of approximately 8.0% during the forecast period. The key influencing factors include the increased prevalence of smoking, poor diet, consumption of alcohol is highest amongst LAMEA’s, this gives rise to lifestyle-related diseases such as diabetes, stroke, heart-related disorders, cancer and so on are leading causes of mortalities amongst women in this region. Thus, augmenting the growth of the LAMEA women health diagnostics market.

The LAMEA women health diagnostics owing to advancement in medical healthcare facilities which encourage the women diagnostics market in the forecast year. Government support and involvement of WHO from the last two decades enable to promote awareness and also promoted health coverage and Insurance in low-middle income countries. Fatality affects women aged above 40 as they may suffer from both diabetes and heart diseases such as CVD in the region. 

Visit for Global Women Health Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size

Rising healthcare spending, overgrowing women health disorders and so on are some of the major pivotal factors which augment the women health diagnostics market in the Middle East and North African region. The most prevailing diseases in women include osteoporosis, menopause, breast cancer, and urinary incontinence. Though, based on the evolving health markets, key trends such as declining fertility rates, enhanced education for women, and enlarged female participation in the workforce and lifestyle improvement impacted women’s health in the current scenario, which affects the growth of the market.

The companies which are contributing significantly in the LAMEA women health diagnostics market include Abbott Laboratories, Inc., Becton, Dickson and Co., Biomerieux SA, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corp., General Electric Co., Hologic, Inc., Koninklijke Philips N.V., Siemens AG, and Thermo Fisher Scientific Inc. among others. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Research Methodology

The market study of the LAMEA Women Health Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. LAMEA Women Health Diagnostics Market Research and Analysis by Application

2. LAMEA Women Health Diagnostics Market Research and Analysis by End-user

The Report Covers

  • Comprehensive research methodology of the LAMEA Women Health Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the LAMEA Women Health Diagnostics market.
  • Insights about market determinants which are stimulating the LAMEA Women Health Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. LAMEA Women Health Diagnostics Market by Applications

5.1.1. Breast Cancer Testing

5.1.2. Cervical Cancer Testing

5.1.3. Pregnancy & Fertility Testing

5.1.4. Ovarian Cancer Testing

5.1.5. Infectious Disease Testing

5.1.6. Ultrasound Tests 

5.1.7. Sexually Transmitted Disease Testing

5.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)

5.2. LAMEA Women Health Diagnostics Market by End-User

5.2.1. Diagnostic and Imaging Centers

5.2.2. Hospitals and Clinics

5.2.3. Home Care 

6. Regional Analysis

6.1. Brazil 

6.2. Argentina

6.3. UAE

6.4. South Africa

6.5. Nigeria 

6.6. Rest of LAMEA 

7. Company Profiles

7.1. Abbott Laboratories, Inc.

7.2. Becton, Dickson and Co.

7.3. Biomerieux SA

7.4. F. Hoffmann-La Roche Ltd.

7.5. Fujifilm Holdings Corp.

7.6. General Electric Co.

7.7. Hologic, Inc.

7.8. Koninklijke Philips N.V. 

7.9. Siemens AG

7.10.  Thermo Fisher Scientific Inc.

1. LAMEA WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

2. LAMEA WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

3. LAMEA WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)


1. LAMEA WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

2. LAMEA WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)

3. LAMEA WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. BRAZIL WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)

5. ARGENTINA WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)

6. UAE WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)

7. SOUTH AFRICA WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)

8. NIGERIA WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)

9. REST OF LAMEA WOMEN HEALTH DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)